₹359.25
−7.56%NSE close, 16 Nov 2026
−20.20%
Gujarat Themis Biosyn is a small cap company, listed on NSE under the symbol GUJTHEM. At ₹359.25 a share, the market values the whole company at ₹4,676 crore.
In FY26, it reported sales of ₹166 crore and a net profit of ₹47 crore, an operating margin of 45.5%.
The market values the company at 227.2 times its profit over the last twelve months and 4.57 times its book value; its return on equity is 2.0% and its borrowings are 1.41 times its equity.
Promoters hold 59.33% of the shares. Foreign institutions hold 3.80%, and domestic institutions, mutual funds among them, 12.65%.
Over the past year the share price has fallen 20.1%, and it is 23.6% below its 52-week high.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | Mar 2025 S | Jun 2025 S | Sep 2025 S | Dec 2025 S | Mar 2026 S | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|
| Sales |
Cessation of Mr. Vineet Ganesh Gawankar as Company Secretary & Compliance Officer of the company w.e.f. November 30, 2026.
Please refer to the attachment.
The financial results for the period ended September 30, 2026.
| 35.9 |
| 42.4 |
| 43.4 |
| 44.2 |
| 43.8 |
| 49.9 |
| Expenses | 21.7 | 21.9 | 21.4 | 22.1 | 24.9 | 23.0 | 50.8 |
|---|
| Operating profit | 16.0 | 13.9 | 21.0 | 21.3 | 19.4 | 20.8 | −0.9 |
|---|
| Operating margin | 42.5% | 38.8% | 49.5% | 49.1% | 43.8% | 47.5% | -1.8% |
|---|
| Other income | 1.4 | 0.3 | 0.8 | 0.4 | 0.9 | 0.1 | 3.8 |
|---|
| Interest | 0.1 | 0.0 | 0.0 | 1.0 | 1.9 | 1.8 | 8.4 |
|---|
| Depreciation | 1.2 | 2.0 | 3.0 | 3.9 | 4.0 | 4.0 | 4.5 |
|---|
| Profit before tax | 16.1 | 12.1 | 18.8 | 16.9 | 14.3 | 15.2 | −11.2 |
|---|
| Tax | 4.1 | 3.1 | 4.5 | 4.4 | 3.5 | 4.1 | 2.7 |
|---|
| Net profit | 12.0 | 9.1 | 14.3 | 12.5 | 10.9 | 11.1 | −13.8 |
|---|
| EPS (₹) | 1.10 | 0.83 | 1.31 | 1.14 | 1.00 | 1.02 | -1.19 |
|---|
₹ crore, financial years to March.
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | 91.0 | 48.8 | −4.9 |
| From investing | −112 | −172 | −1,121 |
| From financing | 26.0 | 115 | 1,266 |
| Spent on fixed assets | −116 | −173 | −54.0 |
| Free cash flow | −25.1 | −124 | −58.9 |
Margins, returns, debt, tax and cash.
| Line | FY25 | FY26 |
|---|---|---|
| Net margin | 32.3% | 28.2% |
| Operating margin | 45.6% | 45.5% |
| Return on equity | 19.6% | 16.2% |
| Return on capital employed | 23.7% | 14.5% |
| Return on assets | 16.2% | 9.3% |
| Debt to equity | 0.12 | 0.56 |
| Interest coverage | 183.10 | 22.00 |
| Debt to assets | 0.10 | 0.32 |
| Current ratio | 2.53 | 1.12 |
| Quick ratio | 2.28 | 0.93 |
| Cash ratio | 0.57 | 0.04 |
| Asset turnover | 0.50 | 0.33 |
| Fixed asset turnover | 3.72 | 0.58 |
| Inventory turnover | 4.90 | 1.40 |
| Receivables turnover | 4.80 | 2.70 |
| Gross margin | 83.8% | 87.1% |
| Cash from operations to profit | 187.0% | 104.0% |
| Effective tax rate | 25.6% | 24.8% |
Schedule of meet
Schedule of meet
Scrutinizer's Report of 45th Annual General Meeting of the Company counter signed by the Chairman.
A copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Revised outcome of 45th Annual General Meeting of the Company due to typographical error.